Higher IL-6 levels and a greater number of T helper 17 (Th17) cells were observed in ICI-induced immune-related enterocolitis, and IL-6 inhibition increased the ICI-induced anti-tumor efficacy [146]. The gene discussed is IL6; the disease is neoplasm.